$GKOS
GLAUKOS Corp

2021 Q4 Form 10-Q Financial Statement

#000155837021015090 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $73.24M $74.71M $64.83M
YoY Change 0.01% 15.24% 10.81%
Cost Of Revenue $16.87M $15.37M $17.93M
YoY Change -13.91% -14.29% 132.79%
Gross Profit $56.38M $59.34M $46.90M
YoY Change 5.09% 26.53% -7.69%
Gross Profit Margin 76.97% 79.43% 72.34%
Selling, General & Admin $47.57M $44.47M $38.95M
YoY Change 8.62% 14.18% -12.37%
% of Gross Profit 84.37% 74.94% 83.04%
Research & Development $26.68M $28.85M $20.30M
YoY Change 25.58% 42.07% 17.51%
% of Gross Profit 47.32% 48.61% 43.29%
Depreciation & Amortization $26.19M $7.390M $7.340M
YoY Change 253.86% 0.68% 680.85%
% of Gross Profit 46.45% 12.45% 15.65%
Operating Expenses $74.24M $48.32M $59.25M
YoY Change 14.16% -18.46% -6.28%
Operating Profit -$17.87M $11.02M -$12.35M
YoY Change 56.86% -189.25% -0.51%
Interest Expense -$3.152M -$3.122M -$5.140M
YoY Change -38.56% -39.26% 504.71%
% of Operating Profit -28.32%
Other Income/Expense, Net -$4.366M -$4.592M -$4.285M
YoY Change 74.71% 7.16% 374.0%
Pretax Income -$22.24M $6.432M -$16.64M
YoY Change 60.08% -138.66% 24.91%
Income Tax -$363.0K $202.0K -$889.0K
% Of Pretax Income 3.14%
Net Earnings -$21.87M $6.230M -$15.75M
YoY Change 105.41% -139.56% 16.6%
Net Earnings / Revenue -29.86% 8.34% -24.29%
Basic Earnings Per Share -$0.47 $0.13 -$0.35
Diluted Earnings Per Share -$0.47 $0.13 -$0.35
COMMON SHARES
Basic Shares Outstanding 46.89M 46.74M 44.71M
Diluted Shares Outstanding 49.32M 44.71M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $414.1M $429.0M $388.4M
YoY Change 2.39% 10.44% 154.02%
Cash & Equivalents $100.7M $113.1M $80.99M
Short-Term Investments $313.3M $315.8M $307.4M
Other Short-Term Assets $15.63M $17.89M $13.20M
YoY Change 18.38% 35.51% -31.25%
Inventory $23.01M $19.72M $19.89M
Prepaid Expenses
Receivables $33.44M $35.24M $32.89M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $486.1M $501.8M $454.4M
YoY Change 3.55% 10.42% 117.14%
LONG-TERM ASSETS
Property, Plant & Equipment $68.97M $60.80M $23.41M
YoY Change 187.28% 159.74% 16.82%
Goodwill $66.13M $66.13M $66.13M
YoY Change 0.0% 0.0%
Intangibles $332.8M $339.0M $363.9M
YoY Change -6.96% -6.85%
Long-Term Investments
YoY Change
Other Assets $18.52M $18.02M $15.90M
YoY Change 10.26% 13.31% 28.23%
Total Long-Term Assets $563.6M $562.3M $540.1M
YoY Change 5.13% 4.12% 450.26%
TOTAL ASSETS
Total Short-Term Assets $486.1M $501.8M $454.4M
Total Long-Term Assets $563.6M $562.3M $540.1M
Total Assets $1.050B $1.064B $994.5M
YoY Change 4.4% 7.0% 223.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.333M $8.459M $6.774M
YoY Change 67.76% 24.87% 93.49%
Accrued Expenses $56.03M $54.99M $39.92M
YoY Change 23.6% 37.76% 34.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.36M $63.45M $46.69M
YoY Change 27.48% 35.89% 41.05%
LONG-TERM LIABILITIES
Long-Term Debt $352.7M $352.5M $247.4M
YoY Change 41.03% 42.48% 259.07%
Other Long-Term Liabilities $9.494M $8.981M $5.982M
YoY Change 35.07% 50.13% 51.06%
Total Long-Term Liabilities $9.494M $8.981M $5.982M
YoY Change 35.07% 50.13% 51.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.36M $63.45M $46.69M
Total Long-Term Liabilities $9.494M $8.981M $5.982M
Total Liabilities $462.5M $463.1M $333.0M
YoY Change 36.83% 39.08% 183.8%
SHAREHOLDERS EQUITY
Retained Earnings -$365.2M -$343.3M -$299.4M
YoY Change 17.79% 14.67% 32.31%
Common Stock $952.5M $943.5M $959.2M
YoY Change -2.47% -1.64% 131.31%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K $132.0K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $28.00K $28.00K $28.00K
Shareholders Equity $587.2M $601.0M $661.6M
YoY Change
Total Liabilities & Shareholders Equity $1.050B $1.064B $994.5M
YoY Change 4.4% 7.0% 223.49%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$21.87M $6.230M -$15.75M
YoY Change 105.41% -139.56% 16.6%
Depreciation, Depletion And Amortization $26.19M $7.390M $7.340M
YoY Change 253.86% 0.68% 680.85%
Cash From Operating Activities -$4.651M $17.79M -$9.570M
YoY Change -143.88% -285.89% 220.07%
INVESTING ACTIVITIES
Capital Expenditures -$9.327M -$9.916M -$1.280M
YoY Change 333.81% 674.69% 26.73%
Acquisitions
YoY Change
Other Investing Activities $455.0K -$16.15M -$180.3M
YoY Change -134.47% -91.04% 5772.31%
Cash From Investing Activities -$8.872M -$26.06M -$181.6M
YoY Change 156.42% -85.64% 4350.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.617M 3.867M 5.820M
YoY Change -81.33% -33.56% -12.61%
NET CHANGE
Cash From Operating Activities -4.651M 17.79M -9.570M
Cash From Investing Activities -8.872M -26.06M -181.6M
Cash From Financing Activities 1.617M 3.867M 5.820M
Net Change In Cash -11.91M -4.406M -185.3M
YoY Change -175.35% -97.62% 45097.56%
FREE CASH FLOW
Cash From Operating Activities -$4.651M $17.79M -$9.570M
Capital Expenditures -$9.327M -$9.916M -$1.280M
Free Cash Flow $4.676M $27.71M -$8.290M
YoY Change -63.33% -434.21% 318.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001192448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17932000
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37463
dei Entity Address City Or Town
EntityAddressCityOrTown
San Clemente
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
dei Entity Address Address Line1
EntityAddressAddressLine1
229 Avenida Fabricante
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92672
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
367-9600
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
GKOS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46890175
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113131000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96596000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
315834000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
307772000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35236000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36059000
CY2021Q3 us-gaap Inventory Net
InventoryNet
19720000
CY2020Q4 us-gaap Inventory Net
InventoryNet
15809000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17887000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13206000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
501808000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
469442000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9416000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9566000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60800000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24008000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28734000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20009000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
49627000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
51443000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
339009000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
357693000
CY2021Q3 us-gaap Goodwill
Goodwill
66134000
CY2020Q4 us-gaap Goodwill
Goodwill
66134000
CY2021Q3 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
8601000
CY2020Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
7207000
CY2021Q3 us-gaap Assets
Assets
1064129000
CY2020Q4 us-gaap Assets
Assets
1005502000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8459000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4371000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
63450000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49702000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10512000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8981000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7029000
CY2021Q3 us-gaap Liabilities
Liabilities
463080000
CY2020Q4 us-gaap Liabilities
Liabilities
338053000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54991000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45331000
CY2021Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
279683000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
189416000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29889000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20704000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
72803000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
60690000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8274000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46892000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45275000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46864000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45247000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
47000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
943486000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
976590000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
987000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1004000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-343339000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310058000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
601049000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
667449000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1064129000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1005502000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74710000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64831000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
220771000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151725000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15370000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
30000000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49762000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
72129000
CY2021Q3 us-gaap Gross Profit
GrossProfit
59340000
CY2020Q3 us-gaap Gross Profit
GrossProfit
46899000
us-gaap Gross Profit
GrossProfit
171009000
us-gaap Gross Profit
GrossProfit
79596000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44470000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38947000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131691000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
127609000
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
28846000
CY2020Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
20304000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
74321000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
64148000
CY2021Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
5000000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10000000
CY2021Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
30000000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
48316000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
59251000
us-gaap Operating Expenses
OperatingExpenses
186012000
us-gaap Operating Expenses
OperatingExpenses
191757000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
11024000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12352000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15003000
us-gaap Operating Income Loss
OperatingIncomeLoss
-112161000
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
291000
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
595000
us-gaap Interest And Other Income
InterestAndOtherIncome
1016000
us-gaap Interest And Other Income
InterestAndOtherIncome
1881000
CY2021Q3 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-3413000
CY2020Q3 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-5732000
gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-9948000
gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-8485000
CY2021Q3 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-1470000
CY2020Q3 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
852000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-3097000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
342000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4592000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4285000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12029000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6262000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6432000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16637000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27032000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118423000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
202000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-889000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
689000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6230000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15748000
us-gaap Net Income Loss
NetIncomeLoss
-27721000
us-gaap Net Income Loss
NetIncomeLoss
-109700000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.48
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8723000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.48
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46737000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44706000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
us-gaap Net Income Loss
NetIncomeLoss
-109700000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
369000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-423000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46255000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44302000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49320000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44706000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46255000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44302000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6230000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15748000
us-gaap Net Income Loss
NetIncomeLoss
-27721000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
548000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
141000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-34000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-170000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-565000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
403000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
335000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-593000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
544000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6565000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16341000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27738000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-109156000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667449000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
17035000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8748000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
124000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-16469000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589774000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4525000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7984000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-476000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-17482000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
584325000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3970000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6189000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
335000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
6230000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
601049000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
673272000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4220000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17176000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
641299000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1634000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13062000
CY2020Q2 gkos Convertible Debt Transaction Costs Amount
ConvertibleDebtTransactionCostsAmount
3267000
CY2020Q2 gkos Convertible Debt Taxes Amount
ConvertibleDebtTaxesAmount
12891000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
81554000
CY2020Q2 gkos Adjustments To Additional Paid In Capital Capped Call Transactions
AdjustmentsToAdditionalPaidInCapitalCappedCallTransactions
-35679000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
448000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-39894000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
662424000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5821000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9659000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-593000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-15748000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
661563000
us-gaap Profit Loss
ProfitLoss
-27721000
us-gaap Profit Loss
ProfitLoss
-109700000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3475000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3297000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18684000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18684000
gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
3519000
gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
3836000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1030000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3234000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-72000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-9340000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-287000
us-gaap Share Based Compensation
ShareBasedCompensation
22921000
us-gaap Share Based Compensation
ShareBasedCompensation
37733000
gkos Stock Option Plan Expenses
StockOptionPlanExpenses
-3172000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1836000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-22000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
773000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
229000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
1951000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
3343000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-494000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5629000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4257000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22578000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-5039000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-4329000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11666000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
78084000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38458000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4790000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49360000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201601000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
287500000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
-9614000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6141000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-102000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-218000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29359000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33592000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
191756000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
273798000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
182356000
gkos Payment For Capped Call Transactions
PaymentForCappedCallTransactions
35679000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24383000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10258000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4817000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4025000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3670000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2607000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
555000
gkos Proceeds From Tenant Allowance
ProceedsFromTenantAllowance
12668000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37643000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
253883000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1257000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-126000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16385000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18564000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106162000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122547000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90320000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
307000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
418000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
315643000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
288000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
97000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
315834000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
307014000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
765000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1670000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1418000
CY2021Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
36654000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the accompanying </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">condensed consolidated financial statements relate to revenue recognition, the fair value of the liability component of the Company’s 2.75% convertible notes due 2027 (Convertible Notes), the incremental borrowing rate related to the Company’s leased assets, stock-based compensation expense and the valuation of certain intangible assets related to the Company’s acquisition of Avedro. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, this process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s condensed consolidated financial statements as of and for the three and nine months ended September 30, 2021 reflect the Company’s estimates of the impact of the ongoing COVID-19 pandemic. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, will depend on future developments that are uncertain, including the duration and severity of the COVID-19 outbreak, the severity and transmission rates of new and more contagious and/or vaccine-resistant variants of COVID-19, and the actions taken to contain it or treat COVID-19, including the availability, distribution, rate of public acceptance and efficacy of vaccines for COVID-19<span style="color:#0000ff;">, </span>as well as the economic impact on local, regional, national and international customers and markets. As a result, there may be changes to the Company’s estimates regarding the impact of COVID-19 in future periods.</p>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113131000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96596000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
9416000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
9566000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122547000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106162000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
307772000
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
37729000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
548000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3879000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3513000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
11115000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3290000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
5184000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3274000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5340000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3359000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5500000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
36630000
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
35236000
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
36059000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5966000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5346000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
5695000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3584000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
8059000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6879000
CY2021Q3 us-gaap Inventory Gross
InventoryGross
19720000
CY2020Q4 us-gaap Inventory Gross
InventoryGross
15809000
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
10955000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
10815000
CY2021Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4355000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3728000
CY2021Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
6908000
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3198000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32773000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27590000
CY2021Q3 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
54991000
CY2020Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
45331000
CY2020Q3 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2021Q3 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2021Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
gkos Lessee Operating Lease Period For Lease Termination
LesseeOperatingLeasePeriodForLeaseTermination
P1Y
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-12700000
gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
CY2021Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
107533000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
54493000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
134672000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23428000
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
61869000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31065000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
72803000
CY2021Q3 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
20600000
CY2021Q3 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
46191000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
220109000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27507000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
238793000
CY2021Q3 us-gaap Goodwill
Goodwill
66134000
CY2021Q3 us-gaap Goodwill
Goodwill
66134000
CY2020Q4 us-gaap Goodwill
Goodwill
66134000
CY2020Q4 us-gaap Goodwill
Goodwill
66134000
CY2021Q3 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
46191000
CY2021Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
405143000
CY2020Q4 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27507000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
423827000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6228000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24912000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24912000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24618000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22092000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
117347000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
220109000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74710000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64831000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
220771000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151725000
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6230000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15748000
us-gaap Net Income Loss
NetIncomeLoss
-27721000
us-gaap Net Income Loss
NetIncomeLoss
-109700000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46737000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44706000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46255000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44302000
CY2021Q3 gkos Incremental Common Shares Attributable To Dilutive Effect Of Common Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfCommonStockOptions
2210000
CY2021Q3 gkos Incremental Common Shares Attributable To Unvested Restricted Stock Units
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnits
365000
CY2021Q3 gkos Incremental Common Shares Attributable To Dilutive Effect Of Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan
8000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49320000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44706000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46255000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44302000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.48
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.48
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5799000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5023000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9104000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5092000
gkos Share Based Compensation Number Of Plans
ShareBasedCompensationNumberOfPlans
4
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
gkos Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Percentage On First Anniversary Date Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentageOnFirstAnniversaryDateOfGrant
0.25
gkos Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod
P3Y
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 gkos Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2020Q4 gkos Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6189000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9659000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22921000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34561000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34600000
gkos Share Based Compensation Arrangement By Share Based Payment Award Options Fair Value Adjustment
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueAdjustment
-3200000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
59000000.0
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0314
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0255
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8700000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25000000.0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
22800000
CY2021Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8800000
CY2021Q3 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2021Q3 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2021Q3 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2021Q3 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
1
CY2021Q3 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
600000
CY2021Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
6900000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5200000
CY2021Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
6800000
CY2020Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5300000
gkos Number Of Business Activities
NumberOfBusinessActivities
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-21-015090-index-headers.html Edgar Link pending
0001558370-21-015090-index.html Edgar Link pending
0001558370-21-015090.txt Edgar Link pending
0001558370-21-015090-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkos-20210930.xsd Edgar Link pending
gkos-20210930x10q.htm Edgar Link pending
gkos-20210930x10q_htm.xml Edgar Link completed
gkos-20210930xex31d1.htm Edgar Link pending
gkos-20210930xex31d2.htm Edgar Link pending
gkos-20210930xex32d1.htm Edgar Link pending
gkos-20210930xex32d2.htm Edgar Link pending
gkos-20210930_cal.xml Edgar Link unprocessable
gkos-20210930_def.xml Edgar Link unprocessable
gkos-20210930_lab.xml Edgar Link unprocessable
gkos-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending